The Microdose Psychedelics Capital Conference virtual event will commence on Thursday, March 24, 2022, 1:30 EST, and investors, family officers, budding entrepreneurs, psychedelic researchers, medical & science specialists and health professionals are invited to attend. The agenda of the conference will include discussions, keynotes, and insights from world-class speakers, top companies, as well as the latest IPOs, all addressing the potential and scope of investments in the psychedelic sector.
The conference will explore specific opportunities in the psychedelic investment sector, along with discussions on the latest innovations in drug development, pertinent laws and regulations, and business trends. This virtual event is a part of the bi-monthly investor series that explores the immense scope of psychedelic investment and connects new businesses to the leading capital industries and investors of the psychedelic arena.
The conference is organized by Microdose, a premier organization focused on creating, offering and distributing the most compelling content on the finance, industry news, science, and the latest breakthroughs and events of the psychedelic industry. This is a robust platform offering exposure to professionals, companies, and individuals about the events of the psychedelic industry.
This PsyCap event will focus on topics like corporate social responsibility (“CSR”), environmental, social and governance (“ESG”), market consolidation, and explore the possibilities of a potential investment.
The Doing Good segment of Psychedelic Capital features presentations from a non-profit organization from the industry. At this event, the PsyCap Doing Good presentation is hosted by the World Happiness Foundation.
The introduction of the Microdose event will be given by:
- Patrick Moher, President, Microdose Psycheledics Insights, is a young entrepreneur dedicated to creating unique business opportunities across the social and economic spectrum for budding industries and individuals.
- Richard Skaife, Chair, Microdose, The Conscious Fund, a veteran in mental health technology and investment
The virtual conference will feature corporate presentations from industry veterans like Clearmind Medicine and Med Plant Science, and offers a unique opportunity for growing companies to connect with peers and industry leaders. Investors can gain access to phenomenal pre-IPO investments opportunities across the psychedelic sector.
The Microdose Group’s first investment opportunity is with HIVE Bio which has partnered with Med Plant Science Ltd to enable safe and legal access of psychedelics medicine to patients. Med Plant Science Ltd, is a biotech company focused on developing psychedelic products, from plants and mushrooms.
To learn more, please visit https://ibn.fm/t47sm.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php